Wall Street is generally still bullish for Lilly and sales of tirzepatide, a drug the FDA approved as Mounjaro for diabetes in 2022 ... by a whopping 15% and more big raises could be in the cards.

Employees living with diabetes often face unique challenges, such as managing blood sugar levels, balancing medication, and ...